Endoscopic System Market Analysis, Size, Share & Growth Forecast 2026–2034

Single-Use Disposable Endoscopes Are Gaining Clinical and Commercial Acceptance as an Infection Control and Cost Management Solution.High-level disinfection failures associated with multi-patient reuse of complex flexible endoscopes, including documented carbapenem-resistant Enterobacteriaceae transmission via duodenoscopes in the United States, have intensified hospital procurement interest in single-use platforms that eliminate reprocessing-associated infection risk. The FDA's safety communications on endoscope reprocessing deficiencies between 2015 and 2019 accelerated manufacturer investment in single-use endoscope design, and multiple companies received 510(k) clearances for disposable colonoscopes, duodenoscopes, and bronchoscopes between 2019 and 2023. Ambu received FDA clearance for its single-use flexible bronchoscope in 2016 and subsequently expanded its disposable endoscope portfolio to include cystoscopes and colonoscopes, establishing a commercial framework for single-use endoscopy that competitors including Boston Scientific and Olympus have entered with their own disposable platforms. Hospital adoption of single-use endoscopes is constrained by higher per-procedure cost relative to reprocessed reusable instruments, requiring favorable health technology assessment on total cost of ownership including reprocessing labor and adverse event avoidance.

Artificial Intelligence-Assisted Polyp Detection Systems Are Improving Adenoma Detection Rates in Colonoscopy Programs.Computer-aided detection systems integrated with colonoscopy video processors apply deep learning algorithms trained on large annotated polyp image datasets to flag suspected polyp locations in real-time during the colonoscopy withdrawal phase, alerting endoscopists to areas warranting closer inspection. Published meta-analyses of randomized controlled trials of computer-aided detection colonoscopy document consistent improvements in adenoma detection rate and polyp detection rate compared to standard colonoscopy, with one-year follow-up data suggesting reduced post-colonoscopy colorectal cancer incidence in AI-assisted programs. Fujifilm received FDA marketing authorization for its CAD EYE system for real-time computer-aided polyp detection in 2021, and Medtronic's GI Genius module received FDA authorization the same year as the first dedicated AI colonoscopy detection device. Endoscopist acceptance of AI-assisted detection requires workflow integration that does not disrupt procedure pacing, and performance in real-world endoscopy practice has been shown to vary by lesion morphology and bowel preparation quality.

Endoscope Reprocessing Automation Is Reducing Labor Costs and Standardizing High-Level Disinfection Compliance at High-Volume Hospital Endoscopy Units.Automated endoscope reprocessors with cycle validation, chemical dosing monitoring, and electronic documentation of each reprocessing cycle are replacing manual high-level disinfection in high-volume hospital endoscopy departments seeking workflow efficiency and regulatory documentation compliance. The integration of reprocessor connectivity with hospital endoscopy information systems enables automatic linking of reprocessing records to patient procedure logs, supporting infection traceability requirements. Medivators and Olympus Medical Systems have developed automated endoscope reprocessing platforms with electronic audit trail and consumable usage monitoring capabilities for hospital endoscopy department deployment. Reprocessing automation investment is driven by regulatory inspection pressure and the liability exposure associated with endoscope-transmitted infections, with hospital risk management committees supporting capital expenditure on validated automated systems as an infection control governance measure.

For related market intelligence, see the Surgical Robot Market.